Published in Nutr Metab Cardiovasc Dis on April 05, 2011
Placental growth factor may predict increased left ventricular mass index in patients with mild to moderate chronic kidney disease--a prospective observational study. BMC Nephrol (2013) 0.78
Soluble Receptor for Advanced Glycation End Product Ameliorates Chronic Intermittent Hypoxia Induced Renal Injury, Inflammation, and Apoptosis via P38/JNK Signaling Pathways. Oxid Med Cell Longev (2016) 0.77
Implication of advanced glycation end products (Ages) and their receptor (Rage) on myocardial contractile and mitochondrial functions. Glycoconj J (2016) 0.75
Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria. Lancet (1999) 4.38
Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study. Lancet (2002) 2.92
Low triiodothyronine and survival in end-stage renal disease. Kidney Int (2006) 1.88
Prognostic impact of the indexation of left ventricular mass in patients undergoing dialysis. J Am Soc Nephrol (2001) 1.83
Reproducibility of the response to short-term low salt intake in essential hypertension. J Hypertens (1996) 1.76
Prognostic value of ultrasonographic measurement of carotid intima media thickness in dialysis patients. J Am Soc Nephrol (2001) 1.54
The Kidney Disease: improving Global Outcomes website: comparison of guidelines as a tool for harmonization. Kidney Int (2007) 1.53
Intravenous prostaglandin E1 reduces soluble vascular cell adhesion molecule-1 in peripheral arterial obstructive disease. Am Heart J (2001) 1.50
Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients. J Am Soc Nephrol (2001) 1.46
Antiproteinuric effect of Losartan in patients with chronic renal diseases. Nephrol Dial Transplant (1997) 1.41
Subjective global assessment of nutrition in dialysis patients. Nephrol Dial Transplant (1993) 1.41
Myocardial infarction with normal coronary arteries: a conundrum with multiple aetiologies and variable prognosis: an update. J Intern Med (2007) 1.40
[The inflammatory aspects in the initial phases of atherogenesis]. G Ital Cardiol (1995) 1.39
Platelet radiolabelling with 111 Indium for in vivo studies: a methodological reappraisal. Nucl Med Biol (1995) 1.38
Confounding: what it is and how to deal with it. Kidney Int (2007) 1.37
Olive oil and health: summary of the II international conference on olive oil and health consensus report, Jaén and Córdoba (Spain) 2008. Nutr Metab Cardiovasc Dis (2010) 1.36
Circulating natriuretic peptide concentrations in patients with end-stage renal disease: role of brain natriuretic peptide as a biomarker for ventricular remodeling. Mayo Clin Proc (2001) 1.29
Rationale and design of ACTIVE: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events. Am Heart J (2006) 1.24
Cardiovascular disease determinants in chronic renal failure: clinical approach and treatment. Nephrol Dial Transplant (2001) 1.19
Soluble vascular cell adhesion molecule-1 as a biohumoral correlate of atherosclerosis. Arterioscler Thromb Vasc Biol (1997) 1.17
Ectopic fat and cardiovascular disease: what is the link? Nutr Metab Cardiovasc Dis (2010) 1.17
Does optical coherence tomography identify arterial healing after stenting? An in vivo comparison with histology, in a rabbit carotid model. Heart (2007) 1.12
Estrogens and glucocorticoids inhibit endothelial vascular cell adhesion molecule-1 expression by different transcriptional mechanisms. Circ Res (2000) 1.12
Long-term CAPD patients are volume expanded and display more severe left ventricular hypertrophy than haemodialysis patients. Nephrol Dial Transplant (2001) 1.12
Soluble E-selectin in essential hypertension: a correlate of vascular structural changes. Am J Hypertens (2001) 1.10
In chronic nephropathies prolonged ACE inhibition can induce remission: dynamics of time-dependent changes in GFR. Investigators of the GISEN Group. Gruppo Italiano Studi Epidemiologici in Nefrologia. J Am Soc Nephrol (1999) 1.10
Enalapril (MK421) and its lysine analogue (MK521): a comparison of acute and chronic effects on blood pressure, renin-angiotensin system and sodium excretion in normal man. Br J Clin Pharmacol (1984) 1.10
Global approach to cardiovascular risk in chronic kidney disease: reality and opportunities for intervention. Kidney Int (2006) 1.10
The valuable contribution of observational studies to nephrology. Kidney Int (2007) 1.10
Cardiovascular risk in uraemic patients-is it fully explained by classical risk factors? Nephrol Dial Transplant (2000) 1.09
Nocturnal hypoxemia, night-day arterial pressure changes and left ventricular geometry in dialysis patients. Kidney Int (1998) 1.07
Transplantation of micro- and macroencapsulated piglet islets into mice and monkeys. Transplant Proc (2005) 1.07
Bias in clinical research. Kidney Int (2007) 1.05
ADMA, proteinuria, and insulin resistance in non-diabetic stage I chronic kidney disease. Kidney Int (2006) 1.04
Simvastatin reduces reperfusion injury by modulating nitric oxide synthase expression: an ex vivo study in isolated working rat hearts. Cardiovasc Res (2001) 1.02
Another 'epidemic' of spontaneous rupture of peritoneal catheters. Nephron (1998) 1.02
Inflammation is associated with carotid atherosclerosis in dialysis patients. Creed Investigators. Cardiovascular Risk Extended Evaluation in Dialysis Patients. J Hypertens (2000) 1.01
The effect of a 5-HT antagonist, ketanserin, on blood pressure, the renin-angiotensin system and sympathoadrenal function in normal man. Br J Clin Pharmacol (1983) 1.00
Activity in vitro of resveratrol on granulocyte and monocyte adhesion to endothelium. Am J Clin Nutr (1998) 1.00
Thromboxane-B2 generation during ex-vivo platelet aggregation. J Nucl Med Allied Sci (1985) 0.99
Fibrinogen, mortality and incident cardiovascular complications in end-stage renal failure. J Intern Med (2003) 0.99
Diagnostic potential of cardiac natriuretic peptides in dialysis patients. Kidney Int (2001) 0.99
Diacylglycerol kinase-alpha phosphorylation by Src on Y335 is required for activation, membrane recruitment and Hgf-induced cell motility. Oncogene (2007) 0.98
Endogenous ouabain and cardiomyopathy in dialysis patients. J Intern Med (2007) 0.97
AGEs and carbonyl stress: potential pathogenetic factors of long-term uraemic complications. Nephrol Dial Transplant (2000) 0.97
Measuring disease occurrence. Kidney Int (2007) 0.96
Chronic proteinuric nephropathies. II. Outcomes and response to treatment in a prospective cohort of 352 patients: differences between women and men in relation to the ACE gene polymorphism. Gruppo Italiano di Studi Epidemologici in Nefrologia (Gisen) J Am Soc Nephrol (2000) 0.96
Confounding. Nephron Clin Pract (2010) 0.95
Vasculoprotective effects of oleic acid: epidemiological background and direct vascular antiatherogenic properties. Nutr Metab Cardiovasc Dis (2002) 0.95
Measures of effect: relative risks, odds ratios, risk difference, and 'number needed to treat'. Kidney Int (2007) 0.95
Statins and stroke: evidence for cholesterol-independent effects. Eur Heart J (2002) 0.95
Nitric oxide attenuates vascular smooth muscle cell activation by interferon-gamma. The role of constitutive NF-kappa B activity. J Biol Chem (1996) 0.94
Standard technical procedures for microencapsulation of human islets for graft into nonimmunosuppressed patients with type 1 diabetes mellitus. Transplant Proc (2006) 0.93
Human adipose tissue binds and metabolizes the endocannabinoids anandamide and 2-arachidonoylglycerol. Biochimie (2006) 0.93
Sleep apnea in renal patients. J Am Soc Nephrol (2001) 0.92
Transplantation of pancreatic islets contained in minimal volume microcapsules in diabetic high mammalians. Ann N Y Acad Sci (1999) 0.92
Prediction of left ventricular geometry by clinic, pre-dialysis and 24-h ambulatory BP monitoring in hemodialysis patients: CREED investigators. J Hypertens (1999) 0.91
Studies on overnight insulin requirements and metabolic clearance rate of insulin in normal and diabetic man: relevance to the pathogenesis of the dawn phenomenon. Diabetologia (1986) 0.91
ACE genotype and ACE inhibitors induced renoprotection in chronic proteinuric nephropathies1. Kidney Int (2000) 0.91
Formulating the alginate-polyornithine biocapsule for prolonged stability: evaluation of composition and manufacturing technique. J Biomed Mater Res A (2007) 0.89
The effect of asymptomatic nocturnal hypoglycemia on glycemic control in diabetes mellitus. N Engl J Med (1988) 0.89
Nitrates and endothelial prostacyclin production: studies in vitro. Circulation (1985) 0.89
Effects of intravenous prostacyclin in variant angina. Circulation (1982) 0.88
Autonomic neuropathy is linked to nocturnal hypoxaemia and to concentric hypertrophy and remodelling in dialysis patients. Nephrol Dial Transplant (2001) 0.88
Circulating E-selectin as a risk marker in patients with end-stage renal disease. J Intern Med (2007) 0.88
Waist circumference modifies the relationship between the adipose tissue cytokines leptin and adiponectin and all-cause and cardiovascular mortality in haemodialysis patients. J Intern Med (2010) 0.88
Fibrinogen, inflammation and concentric left ventricular hypertrophy in chronic renal failure. Eur J Clin Invest (2003) 0.88
Hexarelin protects H9c2 cardiomyocytes from doxorubicin-induced cell death. Endocrine (2001) 0.87